Ameritas Investment Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $11.9K | Hold |
4,121
| – | – | ﹤0.01% | 2917 |
|
2025
Q1 | $8.86K | Hold |
4,121
| – | – | ﹤0.01% | 2862 |
|
2024
Q4 | $15.9K | Hold |
4,121
| – | – | ﹤0.01% | 2726 |
|
2024
Q3 | $27K | Hold |
4,121
| – | – | ﹤0.01% | 2504 |
|
2024
Q2 | $29.9K | Buy |
4,121
+2,003
| +95% | +$14.5K | ﹤0.01% | 2429 |
|
2024
Q1 | $16.1K | Hold |
2,118
| – | – | ﹤0.01% | 2651 |
|
2023
Q4 | $9.64K | Hold |
2,118
| – | – | ﹤0.01% | 2850 |
|
2023
Q3 | $8.37K | Hold |
2,118
| – | – | ﹤0.01% | 2886 |
|
2023
Q2 | $6.63K | Buy |
+2,118
| New | +$6.63K | ﹤0.01% | 2995 |
|
2019
Q2 | – | Sell |
-167
| Closed | -$5K | – | 3088 |
|
2019
Q1 | $5K | Hold |
167
| – | – | ﹤0.01% | 2859 |
|
2018
Q4 | $10K | Hold |
167
| – | – | ﹤0.01% | 2664 |
|
2018
Q3 | $23K | Hold |
167
| – | – | ﹤0.01% | 2440 |
|
2018
Q2 | $21K | Buy |
+167
| New | +$21K | ﹤0.01% | 2486 |
|
2017
Q2 | – | Sell |
-106
| Closed | -$6K | – | 3024 |
|
2017
Q1 | $6K | Buy |
+106
| New | +$6K | ﹤0.01% | 2812 |
|